WallStSmart

Crocs Inc (CROX)vsNike Inc (NKE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nike Inc generates 1044% more annual revenue ($46.40B vs $4.05B). CROX leads profitability with a 14.6% profit margin vs 6.7%. CROX appears more attractively valued with a PEG of 1.39. NKE earns a higher WallStSmart Score of 64/100 (C+).

CROX

Buy

62

out of 100

Grade: C+

Growth: 3.3Profit: 6.0Value: 8.7Quality: 5.5
Piotroski: 5/9Altman Z: 2.59

NKE

Buy

64

out of 100

Grade: C+

Growth: 4.7Profit: 6.0Value: 8.0Quality: 6.5
Piotroski: 4/9Altman Z: 2.28
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CROXUndervalued (+30.4%)

Margin of Safety

+30.4%

Fair Value

$118.93

Current Price

$112.48

$6.45 discount

UndervaluedFair: $118.93Overvalued
NKEUndervalued (+63.0%)

Margin of Safety

+63.0%

Fair Value

$168.71

Current Price

$36.80

$131.91 discount

UndervaluedFair: $168.71Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CROX2 strengths · Avg: 9.0/10
P/E RatioValuation
10.1x10/10

Attractively priced relative to earnings

Operating MarginProfitability
24.2%8/10

Strong operational efficiency at 24.2%

NKE5 strengths · Avg: 8.8/10
EPS GrowthGrowth
428.0%10/10

Earnings expanding 428.0% YoY

Market CapQuality
$54.59B9/10

Large-cap with strong market position

Return on EquityProfitability
20.9%9/10

Every $100 of equity generates 21 in profit

P/E RatioValuation
17.5x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$1.50B8/10

Generating 1.5B in free cash flow

Areas to Watch

CROX4 concerns · Avg: 2.8/10
Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Debt/EquityHealth
1.223/10

Elevated debt levels

Return on EquityProfitability
-7.3%2/10

ROE of -7.3% — below average capital efficiency

EPS GrowthGrowth
-4.2%2/10

Earnings declined 4.2%

NKE2 concerns · Avg: 2.5/10
Profit MarginProfitability
6.7%3/10

6.7% margin — thin

Revenue GrowthGrowth
-1.1%2/10

Revenue declined 1.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : CROX

The strongest argument for CROX centers on P/E Ratio, Operating Margin. PEG of 1.39 suggests the stock is reasonably priced for its growth.

Bull Case : NKE

The strongest argument for NKE centers on EPS Growth, Market Cap, Return on Equity. PEG of 1.42 suggests the stock is reasonably priced for its growth.

Bear Case : CROX

The primary concerns for CROX are Revenue Growth, Debt/Equity, Return on Equity.

Bear Case : NKE

The primary concerns for NKE are Profit Margin, Revenue Growth.

Key Dynamics to Monitor

CROX carries more volatility with a beta of 1.51 — expect wider price swings.

CROX is growing revenue faster at 2.6% — sustainability is the question.

NKE generates stronger free cash flow (1.5B), providing more financial flexibility.

Monitor FOOTWEAR & ACCESSORIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NKE scores higher overall (64/100 vs 62/100). CROX offers better value entry with a 30.4% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Crocs Inc

CONSUMER CYCLICAL · FOOTWEAR & ACCESSORIES · USA

Crocs, Inc. designs, develops, manufactures, markets and distributes casual lifestyle footwear and accessories for men, women and children. The company is headquartered in Broomfield, Colorado.

Nike Inc

CONSUMER CYCLICAL · FOOTWEAR & ACCESSORIES · USA

Nike, Inc. is an American multinational corporation that is engaged in the design, development, manufacturing, and worldwide marketing and sales of footwear, apparel, equipment, accessories, and services. The company is headquartered near Beaverton, Oregon, in the Portland metropolitan area. It is the world's largest supplier of athletic shoes and apparel and a major manufacturer of sports equipment.

Visit Website →

Want to dig deeper into these stocks?